Kaiser Permanente

Honolulu, Hawaii 96819

0 studies enrolling now · 6 studies all time

What they study most

CRC, Chronic Limb-Threatening Ischemia, Critical Limb Ischemia, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer, Hypertension, Influenza, KRAS/NRAS Mutation, Metastatic Colorectal Cancer, Metastatic Renal Cell Carcinoma

Studies at this site

• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation — Running, not enrolling
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed
• PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System — Completed
• CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC) — Completed
• Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP) — Completed
• Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV — Completed